Portfolio

APVC Newco

APVC Newco

A new venture developing technologies that will enable future bioelectronic medicines.

Axon Therapies

Axon Therapies

Axon is an early-stage company developing a novel neuromodulation approach to treat heart failure.

Cala Health

Cala Health

Cala is developing novel therapies based on recent neuroscience discoveries from work out of Stanford University’s Bioengineering and Biodesign Programs.

www.calahealth.com
CVRx

CVRx

CVRx is a late-stage company that has developed the second-generation BAROSTIM NEO, a minimally-invasive implantable system and the only device CE Marked for the separate indications of heart failure and resistant hypertension.

www.cvrx.com
NeuSpera Medical

NeuSpera Medical

NeuSpera is developing therapies using its proprietary MidField Powering technology which has the potential to fundamentally change the way neuromodulation therapy is delivered.

www.neuspera.com
SetPoint Medical

SetPoint Medical

SetPoint is developing a novel and potentially transformative approach to treating inflammatory diseases, such as rheumatoid arthritis and inflammatory bowel disease, by using implantable devices that stimulate the body’s inflammatory reflex. The treatments have been developed based on research demonstrating that the immune system can be influenced or regulated by the nervous system; inflammatory diseases were previously thought to be accessible only by molecular medicines.

www.setpointmedical.com